From a patient perspective, hub services can often be a lifeline to managing complicated, chronic conditions. Creating a solution that supports patients who rely on “middle-ground” specialty medications is a necessity for an area that is becoming a larger part of the overall pharmaceutical landscape. The Hub-Lite™ model ores an e client approach to drugs whose cost or pattern of treatment don’t justify the expense of full-edged patient services.